经尿道等离子体电切术治疗前列腺增生131例  

Transurethral plasmakinetic resection of prostate for treatment of benign prostate hyperplasia:report of 131 cases

作　　者：杨凯[1] 朱劲松[1] 戴宇红[1] 

机构地区：[1]安徽医科大学附属安庆市立医院泌尿外科,安徽安庆246003

出　　处：《蚌埠医学院学报》2009年第4期314-316,共3页Journal of Bengbu Medical College

摘　　要：目的：评价经尿道等离子体电切术（transurethral plasmakinetic resection of prostate,TUPKVP）治疗良性前列腺增生（benign prostate hyperplasia,BPH）的有效性及安全性。方法：对131例TUPKVP治疗BPH患者的临床资料进行回顾性分析。结果：131例患者术中出血少,无前列腺电切综合征发生,术后3-6个月,经B超测量膀胱平均剩余尿量由术前120 ml降至14 ml。平均最大尿流率由术前8.5 ml/s降至21.5 ml/s。国际前列腺症状评分术前平均23分,术后平均5.5分;生活质量评分由术前平均5.1分降至术后1.6分,均有明显改善（P〈0.01）,无永久性尿失禁发生。结论：TUPKVP治疗BPH具有安全性高、并发症少、疗效好的优点,值得临床推广应用。Objective：To assess the efficacy and safety of transurethral plasmakinetic resection of prostate （TUPKVP） for treatment of prostate hyperplasia. Methods：The clinical data of one hundred and thirty-one cases of symptomatic BPH treated by TUPKVP were analyzed retrospectively. Results：No severe hemorrhage or syndromes concerning the surgical procedure was observed. All the patients were followed up for 3 to 6 months. The average residual urine volume decreased from 120 ml to 14 ml;the average masimum flow rate increased from 8.5 ml/s to 21.5 ml/s;the average international prostate symptom score decreased from 23 to 5.5;and the average quality of life decreased from 5.1 to 1.6 （P 〈 0.01 ）. No one developed permanent urinary incontinence. Conclusions：It suggests that TUPKVP has the advantages of high efficacy, high safety and less complication. It is worth popularizing.

关 键 词：前列腺疾病 经尿道前列腺切除术 等离子体 

分 类 号：R697.32[医药卫生—泌尿科学]